Wei Li,Michelle E. Leblanc,Weiwen Wang,Philip J. Rosenfeld
申请号：
US16347668
公开号：
US20190315848A1
申请日:
2017.11.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Antibodies specific for secretogranin III (Scg3) are disclosed. Methods of using the antibodies, antigen-bin ding fragments thereof, or pharmaceutical compositions comprising the same in the treatment of diseases such as diabetic retinopathy, neovascular age-related macular degeneration, retinopathy of prematurity, and cancer, are also disclosed.
